Satellos Bioscience Inc.(MSLE)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
No SEC XBRL data
This company has no XBRL financial filings on file with SEC EDGAR. Common for ADRs, recent IPOs, OTC-listed names, and foreign filers that haven't filed 20-F yet.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
MSLE Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Satellos Bioscience Inc. (MSLE), a Healthcare sector company. MSLE is not currently included in 13F Pro's AI-ranked quality universe — this company has no xbrl financial filings on file with sec edgar. common for adrs, recent ipos, otc-listed names, and foreign filers that haven't filed 20-f yet. Top institutional holders of MSLE by reported 13-F value include FRANKLIN RESOURCES, Siren, L.L.C., Point72 Asset Management, L.P., based on the most recent SEC filings. MSLE trades on the Nasdaq exchange and files with the SEC under CIK 1421642. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MSLE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Satellos Bioscience Inc. directly from SEC EDGAR.
AI Insight: MSLE Financial Trends
Insufficient quarterly financial data available to assess operational trends or margin dynamics.
• No quarterly financial statements provided for analysis.
⚠ Obtain quarterly revenue, gross margin, operating margin, and cash flow data to establish baseline trends.
AI Insight: MSLE Ratio Trends
No financial ratio data available to assess operational trends or shareholder value creation.
• Unable to evaluate margin, cash flow, ROIC, leverage, or revenue growth without ratio or income statement data.
⚠ Request full-period financial statements (P&L, balance sheet, cash flow) to establish baseline metrics and monitor performance.
Get alerted when MSLE's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Satellos Bioscience Inc. including:
Top Institutional Holders of MSLE
FRANKLIN RESOURCES INC
$5.3M938,666 shSiren, L.L.C.
$5.0M892,074 shPoint72 Asset Management, L.P.
$3.9M690,778 shAvidity Partners Management LP
$3.1M387,769 shWoodline Partners LP
$2.8M500,432 shSPHERA FUNDS MANAGEMENT LTD.
$2.8M489,207 shSUVRETTA CAPITAL MANAGEMENT, LLC
$2.7M475,000 shSoleus Capital Management, L.P.
$2.3M414,359 shADAGE CAPITAL PARTNERS GP, L.L.C.
$2.1M380,354 shSaturn V Capital Management LP
$2.0M350,000 sh
| Fund | Value | Shares |
|---|---|---|
| FRANKLIN RESOURCES INC | $5.3M | 938,666 |
| Siren, L.L.C. | $5.0M | 892,074 |
| Point72 Asset Management, L.P. | $3.9M | 690,778 |
| Avidity Partners Management LP | $3.1M | 387,769 |
| Woodline Partners LP | $2.8M | 500,432 |
| SPHERA FUNDS MANAGEMENT LTD. | $2.8M | 489,207 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | $2.7M | 475,000 |
| Soleus Capital Management, L.P. | $2.3M | 414,359 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $2.1M | 380,354 |
| Saturn V Capital Management LP | $2.0M | 350,000 |
More Healthcare Companies
View all Healthcare →Put MSLE on your watchlist
Track score changes the day Satellos Bioscience Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is MSLE a good stock to buy?
13F Pro's AI-powered analysis of Satellos Bioscience Inc. (MSLE) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MSLE are available on the MSLE stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own MSLE?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MSLE. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Satellos Bioscience Inc.'s investment landscape.